Method of screening for inhibitors of osteopontin
US7504232B2 · kind B2 · utility
3Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2001 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Apr 5, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Amino acids (136 to 142) and amino acids (162 to 168) of human osteopontin constitute two sites at which osteopontin interacts with α4 integrins. Products capable of disrupting those interactions are useful in therapy, particularly in the treatment of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.